Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

NewAmsterdam Pharma Company N.V. - Ordinary Shares (NQ: NAMS )

13.26 +0.01 (+0.08%)
Streaming Delayed Price Updated: 3:59 PM EDT, Mar 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 16,140
Open 14.21
Bid (Size) 12.51 (1)
Ask (Size) 13.45 (5)
Prev. Close 13.25
Today's Range 13.24 - 14.21
52wk Range 7.520 - 32.88
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
NewAmsterdam Pharma Reports Full Year 2022 Financial Results and Provides Corporate Update
From NewAmsterdam Pharma Company B.V.
Via Globe NewsWire
NewAmsterdam Pharma to Present at Cowen 43rd Annual Health Care Conference
From NewAmsterdam Pharma Company B.V.
Via Globe NewsWire

Performance

YTD
+18.39%
+18.39%
1 Month
+2.16%
+2.16%
3 Month
+21.65%
+21.65%
6 Month
+28.12%
+28.12%
1 Year
+28.12%
+28.12%

More News

Read More
3 Drug Stocks to Watch as Alzheimer’s Clinical Trials End
Via InvestorPlace
NewAmsterdam Pharma to Present at the SVB Securities Global BioPharma Conference
From NewAmsterdam Pharma Company B.V.
Via Globe NewsWire
NewAmsterdam Pharma Appoints John W. Smither to its Board of Directors
From NewAmsterdam Pharma Company B.V.
Via Globe NewsWire
Why AppTech Payments Are Trading Lower By Over 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
US Stocks Mixed; McDonald's Earnings Top Estimates
Via Benzinga
Why Applied UV Shares Are Trading Higher By 46%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Top 5 Health Care Stocks That May Dip
Via Benzinga
Newly Listed NewAmsterdam Pharma Touts Encouraging Data From High Cholesterol Treatment
Via Benzinga
NewAmsterdam Announces Positive Results from ROSE2, Phase 2 Trial Evaluating Obicetrapib in Combination with Ezetimibe as an Adjunct to High-Intensity Statin Therapy
From NewAmsterdam Pharma Company B.V.
Via Globe NewsWire
Alibaba, XPeng, Dada Nexus And Some Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 6, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 20, 2022
Via Benzinga
NewAmsterdam Announces Appointment of David Topper as Chief Financial Officer
From NewAmsterdam Pharma Company B.V.
Via Globe NewsWire
Benzinga's Top Ratings Upgrades, Downgrades For December 19, 2022
Via Benzinga
VectivBio Announces Results of Extraordinary General Meeting
From VectivBio AG
Via Globe NewsWire
Hibbett, Enfusion And Some Other Big Stocks Moving Lower On Tuesday
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Why Taboola Shares Are Trading Higher By Around 53%? Here Are 53 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
CinCor Pharma, Anavex Life Sciences And Some Other Big Stocks Moving Lower On Monday
Via Benzinga
Why DraftKings Shares Are Trading Lower By 5%; Here Are 24 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.